RDNA is vaccine treatment
Muhammad Yasir Khan , 7-9-2021, King AbdulAziz U – BioScience Dept & King Fahad Medical Research Center (also Mohammed Alsaadi, Khalid Alghamdi and Ishtiaq Qadri) https://biomedres.us/fulltexts/BJSTR.MS.ID.005949.php, "Biotechnology and Its Applications in Vaccine Development," Biomedical Journal of Scientific & Technical Research July, 2021, Volume 37, 1 (ermo/sms, Acc:6-8-2022)
Vaccine is a biological substance which stimulates the immune system by introducing a killed, weakened disease causing organism, or its surface protein in healthy body. Vaccines provide acquired immunity against a particular disease. The mode of action of vaccine is either prophylactic (to prevent the future infection) or it could be threptic specifically many cancer vaccines are under experimental stages [1, 2]. The term vaccine or vaccination derived from Variolae vaccinae (smallpox of the cow) was coined for the first time by an English Physician Edward Jenner to describe cow pox. He used the term in 1798 for his long experiments to establish protective role of cow pox against smallpox [3]. According to World Health Organization so far twenty-five (25) licensed vaccines are available for different infectious diseases [4]. The traditional vaccines are either killed microorganism or attenuated one to generate immune response in body after their inoculation. After emergence of Recombinant DNA Technology is a sub-field of Biotechnology remarkable positive impacts were observed on human health. From production of safe proteins, antibodies and gene therapy RDT revolutionized different aspects of biological studies [5].